Multi-centre clinical study evaluating the efficacy of SonoVue™ (BR1), a new ultrasound contrast agent in Doppler investigation of focal hepatic lesions
To access this article, please choose from the options below
PII: S0720-048X(01)00457-0
© 2002 Published by Elsevier Inc.
